Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN : NSDQ)

• Company Description    CollPlant Biotechnologies Ltd. is a regenerative medicine company. It is focused on 3D bioprinting of tissues and organs, medical aesthetics and on developing and commercializing tissue repair products for orthobiologics and advanced wound care markets. CollPlant Biotechnologies Ltd., formerly knonw as CollPlant Holdings Ltd., is based in Rehovot, Israel. Number of Employees: 57

• Price / Volume Information    Yesterday's Closing Price: $2.71 Daily Weekly Monthly 20 Day Moving Average: 29,940 shares Shares Outstanding: 12.72 (millions) Market Capitalization: $34.46 (millions) Beta: 1.61 52 Week High: $5.01 52 Week Low: $1.31 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 3.83% 1.96% 12 Week 80.67% 64.03% Year To Date -24.72% -32.79%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 4 OPPENHEIMER ST. 11TH FLOOR - REHOVOT,L3 7670104 ISR ph: 972-73-232-5600 fax: 972-73-232-5602 daniel@lifesciadvisors.com http://www.collplant.com

• General Corporate Information    Officers Yehiel Tal - Chief Executive Officer Eran Rotem - Deputy Chief Executive Officer and Chief Financial Roger Pomerantz - Chairman of the Board Oren Fahimipoor - Vice President Abraham Havron - Director Peer Information CollPlant Biotechnologies Ltd. Sponsored ADR (CORR.) CollPlant Biotechnologies Ltd. Sponsored ADR (RSPI) CollPlant Biotechnologies Ltd. Sponsored ADR (CGXP) CollPlant Biotechnologies Ltd. Sponsored ADR (BGEN) CollPlant Biotechnologies Ltd. Sponsored ADR (GTBP) CollPlant Biotechnologies Ltd. Sponsored ADR (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: M2R51X116 SIC: 3842 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/26/25 Share - Related Items Shares Outstanding: 12.72 Most Recent Split Date: (:1) Beta: 1.61 Market Capitalization: $34.46 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.38 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.09 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/26/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.76 Price/Cash Flow: - Price / Sales: 14.35 EPS Growth vs. Year Ago Period: 24.32% vs. Previous Quarter: -115.38% Sales Growth vs. Year Ago Period: -28.11% vs. Previous Quarter: -91.29% ROE 06/30/25 - -94.08 03/31/25 - -87.33 12/31/24 - -87.93 ROA 06/30/25 - -68.62 03/31/25 - -65.31 12/31/24 - -67.78 Current Ratio 06/30/25 - 4.60 03/31/25 - 4.48 12/31/24 - 4.44 Quick Ratio 06/30/25 - 4.40 03/31/25 - 4.23 12/31/24 - 4.29 Operating Margin 06/30/25 - -541.34 03/31/25 - -560.92 12/31/24 - -3,225.05 Net Margin 06/30/25 - -541.34 03/31/25 - -560.92 12/31/24 - -3,225.05 Pre-Tax Margin 06/30/25 - -541.34 03/31/25 - -560.92 12/31/24 - -3,225.05 Book Value 06/30/25 - 0.98 03/31/25 - 1.08 12/31/24 - 1.18 Inventory Turnover 06/30/25 - 1.73 03/31/25 - 2.53 12/31/24 - 3.29 Debt-to-Equity 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©